These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Bipolar disorder. Follow-up of lithium therapy in a clinic].
    Author: Agulló Hernández MD, Sanz Osorio MT, Barbarà Berdaguer M, Vallès i Callol V, Garolera Freixa M, Delgado Cruz L, Alberni i Coderch J.
    Journal: Rev Enferm; 2000 Mar; 23(3):177-80. PubMed ID: 10797777.
    Abstract:
    Lithium carbonate is the drug of choice in the prophylactic treatment of bipolar disorder. The purpose of this article is to describe the effective functioning of lithium in a clinical way in our hospital under the control of university graduates in nursing. During the first ten months of its use, 40 patients have been included which led to 122 appointments, absenteeism being 8.62%. 20% (8/40) of the lithium intoxications at the start of the follow-up were inferior to 0.5% mmol/l while at the end, only 5.3% (2/38) fell below 0.5% mmol/l. The average of the lithium intoxications at the end of the study period was significantly higher than in the moment of entrance to the program (p = 0.009). During the study period, three relapses were registered.
    [Abstract] [Full Text] [Related] [New Search]